NASDAQ:QTTB Q32 Bio Q2 2026 Earnings Results & Report $8.71 -0.11 (-1.25%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$8.72 +0.01 (+0.11%) As of 11/13/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Q32 Bio beat analyst earnings expectations in its Q2 2026 results, released August 5, 2026. The company reported EPS of -$0.44 versus the -$0.46 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 5, 2026TimeBefore Market OpensConference Call7:00 AM ET Q32 Bio EPS ResultsActual EPS-$0.44Consensus EPS -$0.46Beat/MissBeat by +$0.02One Year Ago EPSN/AEPS Beat Rate8 of last 8 quartersQ32 Bio Revenue ResultsActual RevenueN/AExpected Revenue$750 thousandBeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Q32 Bio Q2 2026 Earnings FAQ Did Q32 Bio beat earnings estimates for Q2 2026? Q32 Bio (NASDAQ:QTTB) reported earnings of -$0.44 per share for Q2 2026, beating the consensus estimate of -$0.46. The report was announced on Wednesday, August 5, 2026. Q32 Bio Earnings HeadlinesQ32 Bio to Participate in the 2026 Jefferies Global Healthcare Conference in LondonNovember 11, 2026 | prnewswire.comQ32 Bio Reports Q3 Results; Advances Bempikibart Toward Phase 3 In Alopecia AreataNovember 4, 2026 | rttnews.comI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.November 15 at 1:00 AM | Behind the Markets (Ad)Q32 Bio Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateNovember 4, 2026 | prnewswire.comLeerink Partners initiates coverage of Q32 Bio with outperformOctober 13, 2026 | msn.comJefferies Keeps Their Buy Rating on Q32 Bio (QTTB)October 3, 2026 | theglobeandmail.comSee More Q32 Bio Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Q32 Bio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Q32 Bio and other key companies, straight to your email. Email Address About Q32 BioQ32 Bio (NASDAQ:QTTB) is a biotechnology company focused on developing treatments for autoimmune and inflammatory diseases by targeting pathways that regulate the immune system. Its research has centered on biologic medicines designed to restore immune balance and address disease mechanisms. The company’s programs have included ADX-097, a complement C3 inhibitor designed to target activity in affected tissues, and ADX-914, an antibody targeting the interleukin-7 receptor alpha. Q32 Bio has been based in the United States and has advanced its programs through clinical development. Q32 Bio became a publicly traded company in 2024 through a business combination with Homology Medicines. The combined company retained the Q32 Bio name and trades on the Nasdaq under the symbol QTTB.View Q32 Bio ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/13Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCerebras Q3 Results: How Much More Proof Does Wall Street Need?Applied Materials Beats and Raises, But Investors Stay Unconvinced3 Power and Grid Stocks That Could Keep Growing Even if AI Spending SlowsYETI Beat on Earnings, But Its Sales Tell a Different Story Upcoming Earnings Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.